Furthermore, the pharmacology in the active parts was largely uncharacterized, and confirmation of SCB use was hindered by an absence of recognized biomarkers. These know-how gaps prompted experts throughout several disciplines to speedily (1) keep track of, detect and quantify with chromatography/mass spectrometry the ever-modifying contents of he